Latest Conference Articles

JiaDe Yu, MD: Key Signs of Allergic Contact Dermatitis in Children

JiaDe Yu, MD: Key Signs of Allergic Contact Dermatitis in Children

March 11th 2025

AAD

AAD 2025. JiaDe Yu, MD, discusses key clinical signs of pediatric ACD, when to consider patch testing, and how identifying contact allergens can improve patient care.

Elizabeth Swanson, MD: When HSV Causes Big Dermatologic Problems

Elizabeth Swanson, MD: When HSV Causes Big Dermatologic Problems

March 10th 2025

AAD

Elizabeth Swanson, MD, breaks down the role of the Herpes Simplex Virus in 3 special circumstances, part of her AAD 2025 presentation, "Big Rashes In Little Patients."

For Atopic Dermatitis, "The Treatment Drought is Over," Says Expert Dermatologist Emma Guttman, MD, PhD

For Atopic Dermatitis, "The Treatment Drought is Over," Says Expert Dermatologist Emma Guttman, MD, PhD

March 10th 2025

AAD

AAD 2025. Guttman, among the world's foremost researchers in dermatology, toplined how far the field has come in her "Hot Topics" presentation on the final day of the 2025 AAD.

Delgocitinib Data Reveal "Super Responders" in CHE During AAD 2025 Late Breaker

Delgocitinib Data Reveal "Super Responders" in CHE During AAD 2025 Late Breaker

March 10th 2025

AAD

Data on delgocitinib from the DELTA development program highlight efficacy of the topical JAK inhibitor for treatment of chronic hand eczema.

Recognizing Allergic Contact Dermatitis in Children: Expert Pearls at AAD 2025

Recognizing Allergic Contact Dermatitis in Children: Expert Pearls at AAD 2025

March 10th 2025

AAD

JiaDe Yu, MD, shares key takeaways from his presentation on pediatric allergic contact dermatitis.

Brian S. Kim, MD: Why Primary Care Clinicians  Should Prescribe New Treatments for Atopic Dermatitis

Brian S. Kim, MD: Why Primary Care Clinicians Should Prescribe New Treatments for Atopic Dermatitis

March 10th 2025

AAD

Brian S. Kim, MD, a worldwide leader in research into itch and other skin conditions, says the safety profile and ease of use of new treatments for AD mean primary care clinicians should definitely consider prescribing them.

Zabalafin Hydrogel Shows Efficacy in Atopic Dermatitis, Including Cases with Bacterial Infection

Zabalafin Hydrogel Shows Efficacy in Atopic Dermatitis, Including Cases with Bacterial Infection

March 10th 2025

AAD

Data on zabalafin hydrogel topical therapy may offer a single, comprehensive approach to manage AD across multiple disease stages.

The Link Between Itch and Aging, with Daniel Butler, MD

The Link Between Itch and Aging, with Daniel Butler, MD

March 10th 2025

AAD

Daniel Butler, MD, discusses a more complex definition of immunosenescence, and the interplay between aging and itch-related conditions.

The Complexities of Treating Rosacea, with Benjamin Ungar, MD

The Complexities of Treating Rosacea, with Benjamin Ungar, MD

March 10th 2025

AAD

Benjamin Ungar, MD, explains the phenotypic and molecular manifestations of Rosacea, and the work still needed to develop targeted treatments.

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

March 9th 2025

AAD

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.